Metagenomic Profiling of Oral Microbiome Dynamics During Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Patients
Cancer Medicine · 2025
DOI: 10.1002/cam4.70589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Dominique A Torozan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy and Radiation Oncology, University Hospital, Saarland University, Homburg, Germany. Hauptthemen laut MEDLINE: Microbiota, Chemoradiotherapy, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 European Research Council.
Abstract (Originalsprache)
Background
We explored the interaction between the oral microbiome and the development of radiation‐induced mucositis in patients with head and neck squamous cell cancer (HNSCC) undergoing chemoradiotherapy (CRT). We prospectively studied the oral microbiome and compared it to healthy controls. Additionally, we compared patients with low‐grade (LGM) vs. high‐grade mucositis (HGM).
Methods
Ten HNSCC patients scheduled for CRT were included. Saliva samples were characterized prior to, during, and nine months after CRT using metagenomic sequencing. We similarly characterized samples from seven healthy controls. We assessed alpha and beta diversity and examined abundances at different taxonomic levels between (sub)groups.
Results
Patients exhibited significantly reduced alpha diversity compared to controls at all times (p ⟨ 0.05). Differential abundance of taxa between patients and controls was observed at baseline. In patients, the relative abundance of Staphylococcus aureus and Escherichia coli increased significantly during CRT. Capnocytophaga spp. was associated with the definitive CRT patients' subgroup. At baseline, two fungal families (Melampsoraceae and Herpotrichiellaceaea) were more abundant in patients who later developed HGM. No differentially abundant taxa were found between LGM vs. HGM during irradiation.
Conclusion
Our findings support the hypothesis that CRT, as well as HNSCC itself, influences the composition of the oral microbiome. Microbial markers found in patients who later developed HGM should be evaluated using independent cohorts to qualify their specific biomarker potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiotherapy and Radiation Oncology, University Hospital, Saarland University, Homburg, Germany.
- Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
- Department of Radiotherapy, Westpfalz-Klinikum, Kaiserslautern, Germany.
- Department of Internal Medicine II, Gastroenterology, Hepatology, Endocrinology and Diabetology, University Hospital, Saarland University, Homburg, Germany.
- Department of Life Sciences and Medicine (DLSM), University of Luxembourg, Belvaux, Luxembourg.
ORCID-Profile: Dominique A Torozan, Cédric Christian Laczny, Kirsten Roomp, Paul Wilmes, Jochen G Schneider
Förderung
- H2020 European Research Council
Zitieren
APA
Torozan, D. A., Laczny, C. C., Roomp, K., Wilmes, P., Fleckenstein, J., & Schneider, J. G. (2025). Metagenomic Profiling of Oral Microbiome Dynamics During Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Patients. Cancer Medicine. https://doi.org/10.1002/cam4.70589
Vancouver
Torozan DA, Laczny CC, Roomp K, Wilmes P, Fleckenstein J, Schneider JG. Metagenomic Profiling of Oral Microbiome Dynamics During Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Patients. Cancer Medicine. 2025. doi:10.1002/cam4.70589
BibTeX
@article{Torozan2025,
author = {Torozan, Dominique A and Laczny, Cédric Christian and Roomp, Kirsten and Wilmes, Paul and Fleckenstein, Jochen and Schneider, Jochen G},
title = {Metagenomic Profiling of Oral Microbiome Dynamics During Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Patients},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70589}
}
EUVIMED